Abstract
Purpose
Post-operative urinary retention (POUR) is a known complication of hernia surgery. Minimally invasive inguinal hernia repair (IHR) is typically done under general anesthesia with neuromuscular blockade (NMB), which is commonly reversed with an anticholinesterase inhibitor paired with an anticholinergic agent. Sugammadex is a unique NMB reversal agent that does not have to be paired with an anticholinergic. We sought to explore the role of sugammadex in reducing the rate of POUR following these procedures.
Methods
Data were collected retrospectively at a single institution between February 2016 and October 2019. We identified and studied patients who underwent minimally invasive IHR and received either sugammadex or neostigmine/glycopyrrolate for NMB reversal. The primary endpoint was POUR requiring bladder catheterization. Secondary endpoints included post-operative and 30-day readmissions.
Results
274 patients were included in this study (143 received neostigmine and glycopyrrolate, 131 sugammadex). The sugammadex patients were on average 5 years older than the neostigmine/ glycopyrrolate patients (63.2 vs 58.2, p = 0.003), and received less median intravenous fluids (IVF) (900 ml vs 1000 ml; p = 0.015). There was a significant difference in the rate of POUR between the sugammadex and neostigmine/glycopyrrolate patients (0.0% vs 8.4%, p ≤ 0.001). The difference remained significant after controlling for age and IVF. The odds of POUR for those who received neostigmine/glycopyrrolate were 25 × higher than the odds of those who received sugammadex.
Conclusion
The results of this study reflect the protective role of sugammadex against POUR in minimally invasive IHR cases.
Similar content being viewed by others
Data availability
Not applicable.
Abbreviations
- IHR:
-
Inguinal hernia repair
- POUR:
-
Post Operative Urinary Retention
- NMB:
-
Neuromuscular blockade
- BMI:
-
Body Mass Index
- ASA:
-
American Society of Anesthesia class
- ESRD:
-
End-stage renal disease
- BPH:
-
Benign prostatic hyperplasia
- IVF:
-
Intravenous fluids
- EBL:
-
Estimated blood loss
- NGP:
-
Neostigmine/Glycopyrrolate
References
Simons MP, Smietanski M, Bonjer HJ et al (2018) International guidelines for groin hernia management. Hernia 22:1–165. https://doi.org/10.1007/S10029-017-1668-X
Blair AB, Dwarakanath A, Mehta A et al (2017) Postoperative urinary retention after inguinal hernia repair: a single institution experience. Hernia 21:895–900. https://doi.org/10.1007/S10029-017-1661-4
Hudak KE, Frelich MJ, Rettenmaier CR et al (2015) Surgery duration predicts urinary retention after inguinal herniorrhaphy: a single institution review. Surg Endosc 29:3246–3250. https://doi.org/10.1007/S00464-015-4068-2
Drissi F, Gillion JF, Roquilly A et al (2020) Nationwide analysis of urinary retention following inguinal hernia repair: results from the national prospective hernia registry. World J Surg 44:2638–2646. https://doi.org/10.1007/S00268-020-05538-7
Chang HC, Liu SY, Lee MJ et al (2022) Sugammadex reversal of muscle relaxant blockade provided less post-anesthesia care unit adverse effects than neostigmine/glycopyrrolate. J Formos Med Assoc 121:2639–2643. https://doi.org/10.1016/J.JFMA.2022.04.017
Ostheimer GW (1977) A comparison of glycopyrrolate and atropine during reversal of nondepolarizing neuromuscular block with neostigmine. Anesth Analg 56:182–186. https://doi.org/10.1213/00000539-197703000-00004
Brostrøm S, Hallas J (2009) Persistence of antimuscarinic drug use. Eur J Clin Pharmacol 65:309–314. https://doi.org/10.1007/S00228-008-0600-9
Scott AJ, Mason SE, Langdon AJ et al (2018) Prospective risk factor analysis for the development of post-operative urinary retention following ambulatory general surgery. World J Surg 42:3874–3879. https://doi.org/10.1007/S00268-018-4697-4
Croghan SM, Mohan HM, Breen KJ et al (2023) Global Incidence and risk factors associated with postoperative urinary retention following elective inguinal hernia repair: the retention of urine after inguinal hernia elective repair (RETAINER I) study. JAMA Surg 158:865–873. https://doi.org/10.1001/JAMASURG.2023.2137
Broderick RC, Li JZ, Blitzer RR et al (2022) A steady stream of knowledge: decreased urinary retention after implementation of ERAS protocols in ambulatory minimally invasive inguinal hernia repair. Surg Endosc 36:6742–6750. https://doi.org/10.1007/S00464-021-08950-9
Chau LC, Jarman A, Prater A et al (2023) Effect of neuromuscular blockade reversal on post-operative urinary retention following inguinal herniorrhaphy. Hernia. https://doi.org/10.1007/S10029-023-02857-1
Di Natale S, Slieker J, Soppe S et al (2021) Risk factors for postoperative urinary retention after endoscopic hernia repair: age and unilateral operation make the difference. World J Surg 45:3616–3622. https://doi.org/10.1007/S00268-021-06292-0
Kim SG, Son J, Lee SR, Jung KU (2021) Laparoscopic repair of inguinal hernias: Risk factors for urinary retention and chronic pain after totally extraperitoneal repair and transabdominal preperitoneal repair. J Minim Invasive Surg 24:215–222. https://doi.org/10.7602/JMIS.2021.24.4.215
Patel JA, Kaufman AS, Howard RS et al (2015) Risk factors for urinary retention after laparoscopic inguinal hernia repairs. Surg Endosc 29:3140–3145. https://doi.org/10.1007/S00464-014-4039-Z
Koch CA, Grinberg GG, Farley DR (2006) Incidence and risk factors for urinary retention after endoscopic hernia repair. Am J Surg 191:381–385. https://doi.org/10.1016/J.AMJSURG.2005.10.042
Kheterpal S, Vaughn MT, Dubovoy TZ et al (2020) Sugammadex versus neostigmine for reversal of neuromuscular blockade and postoperative pulmonary complications (STRONGER): a multicenter matched cohort analysis. Anesthesiology 132:1371–1381. https://doi.org/10.1097/ALN.0000000000003256
Deng J, Balouch M, Albrink M, Camporesi EM (2021) Sugammadex reduces PACU recovery time after abdominal surgery compared with neostigmine. South Med J 114:644–648. https://doi.org/10.14423/SMJ.0000000000001304
Ekinci O, Gulmez DD, Subasi FD et al (2022) Neostigmine versus sugammadex on post-operative recovery following bariatric surgery. North Clin Istanb 9:311–316. https://doi.org/10.14744/NCI.2021.94715
Funding
This study received no funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors (Ioannis Tsouknidas, Stephanie Perez, Emily Kunkel, Chidinma Tiko-Okoye, Meghan E Buckley, and Jonathan Y Gefen) declare that they have no conflict of interest.
Ethical approval
The study was approved by the IRB of Main Line Health as Exempt Research with Waiver of HIPAA Authorization.
Human and animal rights
No animal experiments were performed in this study. All procedures performed in studies involving human participants were in accordance with the ethical standards of our institutional research committee.
Informed consent
This retrospective study involved analysis of de-indified data, so informed consent was waived by the IRB of Main Line Health.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Tsouknidas, I., Perez, S., Kunkel, E. et al. Use of sugammadex in prevention of post-operative urinary retention in minimally invasive hernia surgery. Hernia (2024). https://doi.org/10.1007/s10029-024-03038-4
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10029-024-03038-4